Fig. 6From: Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndromeSensitivity analysis showing that if amniotic membrane needs to be reimplanted >79% of the time at month 4, then Cyclosporine A (Restasis) is the less expensive optionBack to article page